Download PDF
Semin Thromb Hemost
DOI: 10.1055/s-0045-1809162
Review Article

Global Hemostasis Testing in Chronic Kidney Disease—Are They Better Predictors of Bleeding and Thrombosis Risk?

Authors

  • Hui Yin Lim 

    1   Northern Clinical Diagnostics and Thrombovascular Research (NECTAR), Northern Health, Epping, Victoria, Australia
    2   Department of Hematology, Northern Pathology Victoria, Northern Health, Epping, Victoria, Australia
    3   Department of Medicine, Northern Health, University of Melbourne, Heidelberg, Victoria, Australia

  • Eng Soo Yap

    4   Department of Laboratory Medicine, National University Hospital, Singapore
    5   Department of Laboratory Medicine, Ng Teng Fong Hospital, Singapore

  • Prahlad Ho

    1   Northern Clinical Diagnostics and Thrombovascular Research (NECTAR), Northern Health, Epping, Victoria, Australia
    2   Department of Hematology, Northern Pathology Victoria, Northern Health, Epping, Victoria, Australia
    3   Department of Medicine, Northern Health, University of Melbourne, Heidelberg, Victoria, Australia

Funding H.Y.L. is a Melbourne Postdoctoral Fellow (University of Melbourne, Australia).
Further Information
   Permissions and Reprints

Abstract

Chronic kidney disease (CKD) affects over 10% of the global population and significantly increases the risk of cardiovascular disease as well as arising bleeding. There are alterations in hemostasis, which are multifactorial, involving complex interactions between coagulation, platelets, and the vessel wall. Hemostasis evaluation in CKD is critical for the optimal management of patients. However, conventional coagulation testing and renal function do not fully reflect the hemostatic alterations and do not adequately represent the risk of bleeding and/or thrombosis in patients with CKD. Global hemostatic assays, including thrombin and fibrin generation assays, provide a more wholesome assessment of the process, including the interaction between procoagulants, anticoagulants, platelets, and fibrinolysis. This review critically appraises published studies reporting the use of global coagulation assays to evaluate hemostasis in patients with CKD, as well as associated clinical outcomes.

Keywords

chronic kidney disease - hemostasis - bleeding - cardiovascular disease - thrombin - fibrin


Publication History

Article published online:
15 May 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA